Profits First, Health Second: The Pharmaceutical Industry and the Global South Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap”Commentary Published on 2024-05-182024-09-05 Journal: International Journal of Health Policy and Management [Category] update2024, [키워드] access Pandemic Accord pharmaceutical industry research and development [DOI] 10.34172/ijhpm.2024.8471 PMC 바로가기 [Article Type] Commentary
Academia-pharmaceutical industry linkage: An academic perspectiveResearch Article Published on 2024-04-052024-09-05 Journal: Journal of Pharmaceutical Policy and Practice [Category] update2024, [키워드] pharmaceutical academia pharmaceutical industry research and development [DOI] 10.1080/20523211.2024.2332872 PMC 바로가기 [Article Type] Research Article
Global inequities in access to COVID-19 health products and technologies: A political economy analysisArticle Published on 2023-06-082024-09-05 Journal: Health & Place [Category] update2024, [키워드] access to medicines COVAX COVID-19 COVID-19 technology access pool Global vaccine equity Inequity pharmaceutical industry political economy structural violence TRIPS waiver [DOI] 10.1016/j.healthplace.2023.103051 PMC 바로가기 [Article Type] Article
Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries약물 설계를 위한 인공 지능 및 기계 학습 접근 방식: 제약 산업의 도전과 기회Review Published on 2022-06-012022-09-11 Journal: Molecular diversity [Category] 신약개발, [키워드] addition applied artificial artificial intelligence available data clinical clinical trial clinical trials compounds computer-aided drug design costly Critical critical point decrease deep deep learning Developing disease drug design drug target drugs imaging information intractable machine machine learning machine learning approach momentum overcome pharmaceutical industry Pharmaceutical industry. raised Research resource spread of COVID-19 step Trial Virtual screening [DOI] 10.1007/s11030-021-10326-z PMC 바로가기 [Article Type] Review
Comparative Greenness Metric Estimates for Content Uniformity Testing of Anti-Cov-2, GS-5734 in Commercial Vials: Validated Micellar Electrokinetic Chromatographic Assay상업용 바이알에서 Anti-Cov-2, GS-5734의 함량 균일성 테스트에 대한 비교 녹색도 측정법 추정: 검증된 미셀 동전기 크로마토그래피 분석Article Published on 2022-04-272022-09-11 Journal: Journal of AOAC International [Category] 치료기술, 치료제, [키워드] Analysis Antiviral antiviral drug antiviral properties antiviral property applied approved borate borate buffer can be used clinical trials Community Comparative content coronavirus correlation coefficient COVID-19 drug Drug administration Ebola Ebola virus effective estimate food green GS-5734 harmonization International Conference linear metric pandemic pharmaceutical industry phosphoramidate positive Remdesivir selectivity sensitivity silica sodium sodium dodecyl sulfate solvent sulfate Testing treat Treatment U.S. Food and Drug Administration uniformity urge viruses was used widespread [DOI] 10.1093/jaoacint/qsac001 PMC 바로가기 [Article Type] Article
Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future글로벌 코로나19 백신 불평등: 유통 첫 해의 실패와 미래를 위한 잠재적 솔루션Article Published on 2022-03-072022-09-11 Journal: Frontiers in Public Health [Category] SARS, 변종, [키워드] Affect approach benefit country COVAX COVID-19 COVID-19 vaccine COVID-19 vaccines D develop distribution effective European country facilitate failure Future global pandemic Health Organization herd immunity Host Immunity include inequality intellectual property interface International international cooperation Investment knowledge majority manufacturing—R& not effective pandemic Pharmaceutical Company pharmaceutical industry Potential pricing resulting risk SARS-CoV-2 pandemic solution Support Technology transfer the SARS-CoV-2 transfer vaccination rate vaccination rates Vaccine Vaccines variant World Health Organization Year [DOI] 10.3389/fpubh.2022.821117 PMC 바로가기 [Article Type] Article
What drives innovation? Lessons from COVID-19 R&DArticle Published on 2022-01-242023-06-18 Journal: Journal of health economics [Category] MERS, [키워드] COVID-19 Innovation Market size pharmaceutical industry [DOI] 10.1016/j.jhealeco.2022.102591 PMC 바로가기 [Article Type] Article
Trust in Medicine as a Factor Conditioning Behaviors Recommended by Healthcare Experts during the COVID-19 Pandemic in PolandArticle Published on 2022-01-052022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] analysis of variance Behavior Conditioning conducted COVID-19 COVID-19 pandemic effort evaluate expert expressed Factor feature Health healthcare healthcare professionals Medicine Medicines moderate nine pharmaceutical industry Poland POLE professionals public health recommendations responsible second wave significantly higher socio-demographic Trust Vaccines [DOI] 10.3390/ijerph19010605 PMC 바로가기 [Article Type] Article
Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a Review제약 연구 및 개발의 기계 학습 및 인공 지능: 검토Review Published on 2022-01-042022-09-11 Journal: The AAPS Journal [Category] 비임상, [키워드] accelerate Analysis anticipated approach artificial artificial intelligence automated breath clinical clinical trial Clinical trial design clinical trials COVID-19 pandemic Critical driven by drug Drug development Drug discovery Efficiency expected help Hope increase in Inference inferences intelligence machine machine learning manuscript market occur offer over Patient pharmaceutical pharmaceutical industry positive precision medicine Predictive Predictive modeling Probability of success recognize Research research and development review Risk-based monitoring. Trial utilization Volume [DOI] 10.1208/s12248-021-00644-3 PMC 바로가기 [Article Type] Review
Understanding Quality Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP Quality Advisory Group진화하는 제약 환경에서 품질 패러다임 변화 이해 : USP 품질 자문 그룹의 관점Review Published on 2021-10-152022-08-31 Journal: The AAPS Journal [Category] MERS, 치료제, [키워드] adoption Advanced manufacturing Analytical procedures lifecycle approach approaches changes in collaboration complement COVID-19 crisis data management Digital technologies and performance-based standards flexible focus Globalization group help increasingly lifecycle organization paradigm Paradigm Shifts pharmaceutical pharmaceutical industry procedure product promote Quality recent recognize Regulatory Resilience Risk-based quality management systems shift Supply chain Therapies understanding USP utilization [DOI] 10.1208/s12248-021-00634-5 PMC 바로가기 [Article Type] Review